Concordancy of Immunocytochemistry Profiling of Circulating Tumor Cells with Immunohistochemistry for Analysis of Therapeutically Relevant Biomarkers.JCO 39, no. 15_suppl (May 20, 2021) 3047-3047. Published online May 28, 2021. |
 Abstract PS2-40: Analytical and Clinical Validation of the Trucheck™ Platform for Diagnostic Triaging of Symptomatic Cases Suspected of Breast Cancer
|
Abstract PS4-36: Non-Invasive Evaluation of Chemoresistance in Breast Cancers using Circulating Tumor Associated Cells
|
Abstract PS3-13: Non-Invasive Screening for Breast Cancer Risk Based on Circulating Ensembles of Tumor Associated CellsDOI: 10.1158/1538-7445.SABCS20-PS3-13 Published February 2021 |
Analytical and clinical validation of the TruCheck™ platform for diagnostic triaging of symptomatic cases suspected of colorectal cancer
|
 OFP01.05 Circulating Ensembles of Tumor Associated Cells Facilitate Efficient Triaging of Asymptomatic Individuals for Low Dose Computed TomographyVolume 16, Issue 1, Supplement , S10, January 01, 2021. |
PR01.01 Evaluation of Circulating Tumor Cells for Non-Invasively Discerning Lung Primary from MetastasisVolume 16, Issue 1, Supplement , S40, January 01, 2021. |
 Multi Analyte Assay for Non-Invasive Diagnosis of Brain TumorsDOI: 10.1093/neuonc/noaa215.034. Published online 9 November 2020. |
Multi-Analyte Liquid Biopsies Based Treatment in Advanced Refractory CancersDOI: 10.1200/JCO.2020.38.15_suppl.e15623 Journal of Clinical Oncology 38, no. 15_suppl. Published online May 25, 2020. |
Multi-Analyte Interrogation Based Treatment of Advanced Refractory CancersDOI: 10.1200/JCO.2020.38.15_suppl.e15624 Journal of Clinical Oncology 38, no. 15_suppl. Published online May 25, 2020. |
 Encyclopedic Tumor Analysis Guided Treatments with Conventional Drugs Outperform Available Alternatives in Refractory CancersAnnals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-098 |
Clinical Utility of Encyclopedic Tumor Analysis to Treat Patients with Brain Metastasis in Refractory CancersNeuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi59–vi60 |
Abstract B61: Encyclopedic Non-Invasive Liquid Biopsies for Differential Diagnosis in Prostate CancerDOI: 10.1158/1557-3265.LiqBiop20-B61 Published June 2020 |
Abstract B15: Circulating Tumor Cells Express Tissue Specific Antigens in Multiple Cancers
|
 Encyclopedic Tumor Analysis Guided Personalized Treatments for Advanced Refractory Breast Cancer
|
Abstract B17: An mRNA Signature that Accurately Discerns Gliomas from Healthy Individuals
|
 Artificial Intelligence can Detect Lung Cancer from High Resolution Microscopic Images of Conditioned Peripheral Blood
|
Diagnosis of Gliomas Using Circulating Glial CellsNeuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi153 |
Liquid Biopsies to Enable Non-Invasive Real-Time Functional Chemoresistance Profiling in Solid Organ CancersDOI: 10.1200/JCO.2020.38.15_suppl.3525 Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 3525-3525. Published online May 25, 2020. |
In Vitro Chemo Resistance Profiles of Circulating Glial Cells Replicate Chemo Characteristics of Tumor TissueNeuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi135 |
 Tumor Infiltrating Lymphocytes Show in Vitro Cytotoxic Activity Against Tumor Cells in Multiple CancersDOI: 10.1200/JGO.2019.5.suppl.111 Journal of Global Oncology 5, no. suppl (October 07, 2019) 111-111 |
 Clinical Utility of Encyclopedic Tumor Analysis to Treat Breast Cancer Patients who have Failed Standard of Care TreatmentsVolume/Issue: Volume 18: Issue 3.5; Online Publication Date: 20 Mar 2020 |
 Clinical Utility of Encyclopedic Tumour Analysis to Treat Patients with Advanced Refractory Head and Neck CancersAnnals of Oncology, Volume 30, Issue Supplement_9, November 2019, mdz431.008 |
mTOR Inhibitors in Combination Regimens Guided by Encyclopedic Tumour Analysis Show Superior Outcomes Compared to Monotherapy in Refractory CancersAnnals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-115 |
Clinical Efficacy of Combination Therapies with Androgen Receptor Antagonists for Treatment of Multiple Refractory CancersDOI: |
Encyclopedic Tumour Analysis (ETA) Guided Combination Regimens of Hormone Receptor Antagonists with Other Systemic Agents for Treatment of Refractory CancersAnnals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-106 |
Abstract B16: Non-Invasive Liquid Biopsies for Guideline-Compliant Diagnostic Assessment in Ovarian CancersDOI: 10.1158/1557-3265.LiqBiop20-B16 Published June 2020 |
Abstract B62: Wholesome Non-Invasive Liquid Biopsies for Pharmacodiagnostic Work-Up in Breast CancerDOI: 10.1158/1557-3265.LiqBiop20-B62 Published June 2020 |
Encyclopedic Liquid Biopsies for Guideline-Compliant Diagnostic Work-up in Gastrointestinal CancersJournal of Clinical Oncology 38, no. 4_suppl (February 01, 2020) 799-799 |
PD-L1 Profiling of Circulating Tumor Cells for Immune Checkpoint Inhibitor Therapy in Head and Neck CancersJournal of Clinical Oncology 38, no. 5_suppl (February 10, 2020) 36-36 |
PD-L1 Profiling of Circulating Tumor Cells for Immune Checkpoint Inhibitor Therapy in Gastroesophageal CancersJournal of Clinical Oncology 38, no. 5_suppl (February 10, 2020) 29-29 |
Diagnostic Non-Invasive Biopsy can Substitute Conventional Tissue Dependent Procedures in Suspected Cases of Lung CancerJournal of Thoracic Oncology. 2019 Nov 1;14(11):S1137-8 |
 Diagnostic Non-Invasive Biopsy can Substitute Conventional Tissue Dependent Procedures in Suspected Cases of Renal Cell CarcinomaVolume 18, Issue 11, November 2019, Page e3515 |
 Circulating Tumor Associated Cells in Head and Neck Cancers are Resistance Educated per Previous Chemotherapy TreatmentsVolume 106, Issue 5, P1121, April 01, 2020 |
 Abstract P6-10-11: In Vitro Chemo Interrogation of Viable Circulating Tumor Associated Cells from Breast Cancer PatientsDOI: 10.1158/1538-7445.SABCS19-P6-10-11 Published February 2020 |
Effect of Previous Chemotherapy Treatments on Circulating Tumor-Associated Cells in Colorectal CancerJournal of Clinical Oncology 38, no. 4_suppl (February 01, 2020) 194-194 |
Circulating Tumour Associated Cells in Esophageal Cancers are Resistance Educated Per Previous Chemo TreatmentsAnnals of Oncology. 2019 Nov 1;30(Supplement_7):mdz413-050 |
 In Vitro Functional Interrogation of Viable Circulating Tumor Associated Cells (C-TACs) for Evaluating Platin ResistanceAnnals of Oncology. 2019 Oct 1;30(Supplement_5):mdz268-099 |
Abstract A49: Viable Circulating Ensembles of Tumor-Associated Cells Persist in Pretreated Patients with Solid Organ Cancers showing no Radiologically Detectable DiseaseDOI: 10.1158/1557-3265.LiqBiop20-A49 Published June 2020 |
Circulating Microtumors: A functional Hallmark for Cancer Detection and ManagementDOI: 10.1200/JCO.2020.38.15_suppl.3544 Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 3544-3544. Published online May 25, 2020. |
Circulating Ensembles of Tumor-Associated Cells in Genitourinary CancersDOI: 10.1200/JCO.2020.38.6_suppl.718 Journal of Clinical Oncology 38, no. 6_suppl (February 20, 2020) 718-718 |
Abstract P4-01-17: Viable Circulating Ensembles of Tumor Associated Cells Persist in Patients with No Radiologically Detectable Disease after Treatment in Breast Cancer
|
Abstract P4-01-05: Circulating Ensembles of Tumor Associated Cells for Detection of Breast CancerDOI: 10.1158/1538-7445.SABCS19-P4-01-05 Published February 2020 |
Circulating Ensembles of Tumor-Associated Cells in Gastrointestinal CancersJournal of Clinical Oncology 38, no. 4_suppl (February 01, 2020) 808-808 |
 Circulating Ensembles of Tumor Associated Cells are Ubiquitous in Breast, Ovarian and Cervical Cancers and Atypical in Asymptomatic IndividualsYear: 2019 |
 Circulating Ensembles of Tumor Associated Cells are a Reliable Biomarker of Pancreatic CancerPresented at the CRUK Early Detection of Cancer Conference, Stanford, USA |
CONTACT US